Recombinant Virus Zika Virus VLP Suriname Z1106033 Protein
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-14835
![SDS-PAGE: Recombinant Virus Zika Virus VLP Suriname Z1106033 Protein [NBP3-14835]](https://resources.bio-techne.com/images/products/Zika-Virus-VLP-Recombinant-Protein-Antigen-SDS-Page-NBP3-14835-img0001.jpg "SDS-PAGE: Recombinant Virus Zika Virus VLP Suriname Z1106033 Protein [NBP3-14835]")
Discontinued Product
NBP3-14835 has been discontinued.
View all Zika Virus VLP products.
Key Product Details
Source
HEK293
Conjugate
Unconjugated
Applications
SDS-PAGE
Product Specifications
Description
Recombinant Zika Virus serotype 1 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein (NCBI accession #: ALX35659.1, aa 123-819). Protein contains a C-terminal His-tag
Storage: Thaw quickly using a 37C water bath immediately before use. Produce desired aliquot sizes and snap-freeze in liquid nitrogen for storage at -80C. While handling product avoid excessive mixing or shocking to prevent aggregation. To mix product gently pipet up and down. Short and long term storage above -80C may result in aggregate formation.
Concentration: 0.1-0.5mg/ml
Storage: Thaw quickly using a 37C water bath immediately before use. Produce desired aliquot sizes and snap-freeze in liquid nitrogen for storage at -80C. While handling product avoid excessive mixing or shocking to prevent aggregation. To mix product gently pipet up and down. Short and long term storage above -80C may result in aggregate formation.
Concentration: 0.1-0.5mg/ml
Purity
>95% pure by SDS-PAGE
Protein / Peptide Type
Recombinant Protein
Scientific Data Images for Recombinant Virus Zika Virus VLP Suriname Z1106033 Protein
SDS-PAGE: Recombinant Virus Zika Virus VLP Suriname Z1106033 Protein [NBP3-14835]
SDS-Page: Zika Virus VLP Recombinant Protein Antigen [NBP3-14835] - Coomassie-stained SDS-PAGE and Western blot images of ZIKV VLPs.Formulation, Preparation and Storage
NBP3-14835
| Preparation Method | The Zika Virus VLP is produced in human cell lines using state-of-the-art expression techniques. The Zika Virus VLP is composed of partially mature particles containing Envelope (E), pre-Membrane (prM) and Membrane (M), and has been constructed purely from Zika virus sequences. Concentration and purification is then performed by a series of ultracentrifuge and chromatographical methods which result in VLPs of exceptional quality and purity. |
| Formulation | DPBS pH 7.4, 20% Sucrose. May contain traces of tartrate |
| Preservative | No Preservative |
| Concentration | Please see the vial label for concentration. If unlisted please contact technical services. |
| Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Store at -80C. Avoid freeze-thaw cycles. |
Background: Zika Virus VLP
Alternate Names
polyprotein, partial
Product Documents for Recombinant Virus Zika Virus VLP Suriname Z1106033 Protein
Product Specific Notices for Recombinant Virus Zika Virus VLP Suriname Z1106033 Protein
This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...